Malaysia

M’sia to press on with AstraZeneca jabs amid blood clot fears

After halt by several countries, Putrajaya says it will not change stance

Updated 5 years ago · Published on 15 Mar 2021 6:54PM

M’sia to press on with AstraZeneca jabs amid blood clot fears
National Covid-19 Immunisation Programme Coordinating Minister Khairy Jamaluddin at a joint press conference with Health Minister Datuk Seri Dr Adham Baba on the development of national Covid-19 immunisation in Putrajaya today. – Bernama pic, March 15, 2021

PUTRAJAYA – Malaysia will proceed with the purchase and acquisition of AstraZeneca Covid-19 vaccines as there has been no evidence that the vaccine causes blood clots, said National Covid-19 Immunisation Programme Coordinating Minister Khairy Jamaluddin.

He said AstraZeneca had informed Malaysia on the side effects of the vaccine and so far, there has been no data to indicate any direct link between the vaccine and reports of blood clots in people, which had resulted in deaths in a few countries.

“As of now we will not take another stand. The purchase of the AstraZeneca vaccines remains the same,” he told a joint press conference with Health Minister Datuk Seri Dr Adham Baba on the development of the immunisation programme, here, today.

Several countries such as Denmark, Norway, Iceland and Thailand have reportedly paused using AstraZeneca’s vaccine following reports of blood clots occurring in several individuals after being vaccinated.

Khairy, who is also Science, Technology and Innovation Minister, said clinical data on the incidents would be studied. 

He added that the possibility of vaccinating teenagers is being looked at, adding that Pfizer-BioNTech and AstraZeneca were already conducting clinical trials on individuals aged 12 to 16.

Meanwhile, Dr Adham said the National Pharmaceutical Regulatory Division (NPRA) conducts thorough studies on any Covid-19 vaccine to be used in Malaysia.

“We trust the NPRA’s decisions, and in the case of the AstraZeneca vaccine we have looked into its quality and safety,” he said.

The Drug Control Authority (DCA) on March 2 approved the conditional registration of the AstraZeneca Covid-19 vaccine. – Bernama, March 15, 2021

Related News

Malaysia / 2y

Current health ailments not related to AstraZeneca vaccine, says Noor Hisham

Malaysia / 2y

Govt aware of AstraZeneca vaccine side effects when it was deployed, says Noor Hisham

Malaysia / 2y

Govt to address AstraZeneca vaccine worries this week

World / 2y

AstraZeneca Covid-19 vaccine to be withdrawn globally

World / 2y

AstraZeneca admits Covishield can cause blood clots, low platelet count

Malaysia / 2y

Unity Govt cowardly, irresponsible for snuffing out GEG, bowing to pressure: Khairy

Spotlight

Malaysia

MB’s resignation: “I was not informed” – Jalaluddin

Malaysia

Ismail’s resignation raises various questions: Work of hidden hands?

Malaysia

Padang Rengas dispute exposes challenge facing possible BN-PN pact

Malaysia

Khalid urges Anwar to reject Anthony Loke’s resignation amid political uncertainty

By Alfian Z.M. Tahir

Malaysia

Zahid: One name submitted for new Negeri MB

Malaysia

Viral abuse video leads to murder charge against couple in father's death

You may be interested

Malaysia

Data centre boom exposes Malaysia to wider cybersecurity threats, NACSA warns

Malaysia

Police hunt answers after 15-year-old girl shot in neck in Ranau

Malaysia

Less than 3% of RM250m scam losses recovered and returned to victims

Malaysia

All eight victims of Sungai Luit flash flood tragedy found, SAR operation ends

Malaysia

MB’s resignation: “I was not informed” – Jalaluddin

Malaysia

Ismail’s resignation raises various questions: Work of hidden hands?

Malaysia

43MWp solar farm underscores growing corporate role in Malaysia’s energy transition

Malaysia

Policeman killed, four seriously injured in Perak highway crash